Keywords
SARS-CoV-2
Pneumonia, Viral
Respiratory insufficiency
High Flow Nasal Cannula
Intubation, Intratracheal
How to Cite
Abstract
Background: ventilatory support is considered first line for the treatment of acute respiratory failure. Better understanding the relationship between the use of high flow and outcome in patients with COVID-19 is relevant as it has emerged as an alternative to orotracheal intubation. Objective: to determine the effect of high-flow nasal cannula on hospital stay and mortality of patients with SARS-CoV-2 infection and hypoxemic respiratory failure during the years 2020 and 2021 in a national university hospital. Methods: retrospective cohort study was carried out between March 2020 and February 2021, of patients with severe SARS-CoV-2 pneumonia and ventilatory failure. The High Flow Nasal Cannula was evaluated compared to conventional mechanical ventilation. Propensity score was used for stay, mortality and secondary outcomes (bloodstream infection, acute renal failure, among others). Finally, 30-day mortality and live discharge were evaluated using the Poisson model. Results: 160 patients were analyzed (40 with Cannula and 120 with Orotracheal Intubation), 66,9 % being men and average age 63,8 years. 81 patients (50,6 %) died in the first 30 days of hospitalization. After adjustment, no association was found with mortality (RaIR 1,13, 95 % CI: 0,93-1,38), but with shorter stay, frequency of Orotracheal Intubation and acute kidney injury. Conclusion: The group of patients who received a high-flow nasal cannula showed a lower frequency of invasive mechanical ventilation, hospital stay and acute kidney injury not previously described, although no reduction in mortality was found.
References
Organización Mundial de la Salud [internet] Alocución de apertura del Director General de la OMS en la rueda de prensa sobre la COVID-19 celebrada el 11 de marzo de 2020. 2020 mar 11 [citado 2023 oct 30]. Disponible en: https://www.who.int/es/director-general/speeches/detail/who-director-general-s-opening-remarks-at-themedia-briefing-on-covid-19---11-march-2020.
World Health Organization [internet]. WHO COVID-19 dashboard > Cases. [citado 2023 oct 30]. Disponible en: https://data.who.int/dashboards/covid19/cases?n=c.
Islam N, Shkolnikov VM, Acosta RJ, et al. Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries. BMJ med. 2021;373:n1137.
Instituto Nacional de Salud. COVID-19 en Colombia, Corte 07-06-2023. [citado 2023 oct. 30]. Disponible en: https://www.ins.gov.co/Noticias/Paginas/coronavirus-casos.aspx.
Tan E, Song J, Deane AM, Plummer MP. Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis. Chest. 2021;159(2):524-536.
Lim ZJ, Subramaniam A, Ponnapa-Reddy M, Blecher G, Kadam U, Afroz A,et al. Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis. Am J Respir Crit Care Med. 2021;203(1):54-66.
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ med. 2020;368:m1091.
Daugherty SE, Guo Y, Heath K, Dasmariñas MC, Jubilo KG, Samranvedhya J, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373:n1098.
Liaqat A, Mason M, Foster BJ, Kulkarni S, Barlas A, Farooq AM, et al. Evidence-Based Mechanical Ventilatory Strategies in ARDS. J Clin Med. 2022;11(2):319.
Popat B, Jones AT. Invasive and non-invasive mechanical ventilation. Medicine (Abingdon). 2012;40(6):298-304.
Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426.
Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, et al. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021;9(12):1387-1395.
Veiga VC, Silva LMCJ, Sady ÉRR, Maia IS, Cavalcanti AB. Epistaxis as a complication of high-flow nasal cannula therapy in adults. Rev Bras Ter Intensiva. 2022;33(4):640-643.
Sharma S, Danckers M, Sanghavi DK, Chakraborty RK. High-Flow Nasal Cannula. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.
Riviello ED, Kiviri W, Twagirumugabe T, Mueller A, Banner-Goodspeed VM, Officer L, et al. Hospital Incidence and Outcomes of the Acute Respiratory Distress Syndrome Using the Kigali Modification of the Berlin Definition. Am J Respir Crit Care Med. 2016;193(1):52-59.
Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818-824.
Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426.
Schunemann HJ, Khabsa J, Solo K, Khamis AM, Brignardello-Petersen R, El-Harakeh A,et al. Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19: A Living Systematic Review of Multiple Streams of Evidence. Ann Intern Med. 2020;173(3):204-216.
Corley A, Rickard CM, Aitken LM, Johnston A, Barnett A, Fraser JF et al. High-flow nasal cannulae for respiratory support in adult intensive care patients. Cochrane Database Syst Rev. 2017;5:CD010172.
Zhao H, Wang H, Sun F, Lyu S, An Y. Highflow nasal cannula oxygen therapy is superior to conventional oxygen therapy but not to noninvasive mechanical ventilation on intubation rate: a systematic review and meta-analysis. Crit Care. 2017;21(1):184.
Lu X, Xu S. Therapeutic effect of high-flow nasal cannula on severe COVID-19 patients in a makeshift intensive-care unit. Medicine (Baltimore). 2020;99(21):e20393.
Chang CC, Lin YC, Chen TC, Lin JJ, Hsia SH, Chan OW, et al. High-Flow Nasal Cannula Therapy in Children With Acute Respiratory Distress With Hypoxia in A Pediatric Intensive Care UnitA Single Center Experience. Front Pediatr. 2021;9:664180.
Tiruvoipati R, Lewis D, Haji K, Botha J. Highflow nasal oxygen vs high-flow face mask: a randomized crossover trial in extubated patients. J Crit Care. 2010;25(3):463-468.
Cheng LC, Chang SP, Wang JJ, Hsiao SY, Lai CC, Chao CM. The Impact of High-Flow Nasal Cannula on the Outcome of Immunocompromised Patients with Acute Respiratory Failure: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2019;55(10):693.
Izcovich A, Ragusa MA, Tortosa F, Lavena MA, Agnoletti C, Bengolea A, et al. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One. 2020; 15(11):e0241955.
Sun Q, Qiu H, Huang M, Yang Y. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care. 2020;10(1):33.
Dhont S, Derom E, Van E, Depuydt P, Lambrecht BN. The pathophysiology of ‘happy’ hypoxemia in COVID-19. Respir Res. 2020;21(1):198.
Akoumianaki E, Vaporidi K, Bolaki M, Georgopoulos D. Happy or Silent Hypoxia in COVID-19-A Misnomer Born in the Pandemic Era. Front Physiol. 2021;12:745634.
Nishimura K, Yamana K, Fukushima S, Fujioka K, Miyabayashi H, Murabayashi M, et al. Comparison of Two Hepatitis B Vaccination Strategies Targeting Vertical Transmission: A 10- Year Japanese Multicenter Prospective Cohort Study. Vaccines (Basel). 2021;9(1):58.
COVID-19 Treatment Guidelines [Internet]. United States: National Institutes of Health: Nov 2, 2023. COVID-19 Treatment Guidelines [citado 30 de octubre de 2023]. Disponible en: https:// www.covid19treatmentguidelines.nih.gov/.
Saavedra Trujillo, CH. COLOMBIANO DE ATENCIÓN, DIAGNÓSTICO Y MANEJO DE LA INFECCIÓN POR SARS-COV-2/COVID-19 EN ESTABLECIMIENTOS DE ATENCIÓN DE LA SALUD: RECOMENDACIONES BASADAS EN CONSENSO DE EXPERTOS E INFORMADAS EN LA EVIDENCIA ACIN-IETS. SEGUNDA EDICIÓN. Infect. 2020;24(3 Suppl 1):262-292.
Nishimura M. High-Flow Nasal Cannula Oxygen Therapy in Adults: Physiological Benefits, Indication, Clinical Benefits, and Adverse Effects. Respir Care. 2016;61(4):529-41.
Frat JP, Quenot JP, Badie J, Coudroy R, Guitton C, Ehrmann S, et al. Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial. JAMA. 2022;328(12):1212-1222.
Ospina-Tascón GA, Calderón-Tapia LE, García AF, Zarama V, Gómez-Álvarez F, Álvarez-Saa T, Pardo-Otálvaro S, et al. Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021;326(21):2161-2171.
Nair PR, Haritha D, Behera S, Kayina CA, Maitra S, Anand RK, et al. Comparison of High-Flow Nasal Cannula and Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure Due to Severe COVID-19 Pneumonia. Respir Care. 2021;66(12):1824-1830.
Teng XB, Shen Y, Han MF, Yang G, Zha L, Shi JF. The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia. Eur J Clin Invest. 2021;51(3):e13435.
Perkins GD, Ji C, Connolly BA, Couper K, Lall R, Baillie JK, et al. Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial. JAMA. 2022;327(6):546- 558.
Agarwal A, Basmaji J, Muttalib F, Granton D, Chaudhuri D, Hu M, et al. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth. 2020;67(9):1217-1248.
Rochwerg B, Granton D, Wang DX, Helviz Y, Einav S, Frat JP, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med. 2019;45(5):563-572.
Wang K, Zhao W, Li J, Shu W, Duan J. The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China. Ann Intensive Care. 2020;10(1):37.
Mellado-Artigas R, Ferreyro BL, Angriman F, Hernández-Sanz M, Arruti E, Torres A, et al. COVID-19 Spanish ICU Network. High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure. Crit Care. 2021;25(1):58.
Arruda DG, Kieling GA, Melo-Diaz LL. Effectiveness of high-flow nasal cannula therapy on clinical outcomes in adults with COVID-19: A systematic review. Can J Respir Ther. 2023;20(59):52-65.
Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020;52(6):1193-1194.
Kilis-Pstrusinska K, Akutko K, Braksator J, Dancewicz A, Grosman-Dziewiszek P, Jamer T, Juszczyńska K, et al. Kidney Dysfunction and Its Progression in Patients Hospitalized Duo to COVID-19: Contribution to the Clinical Course and Outcomes. J Clin Med. 2021;10(23):5522.
Raoof S, Nava S, Carpati C, Hill NS. High- Flow, Noninvasive Ventilation and Awake (Nonintubation) Proning in Patients With Coronavirus Disease 2019 With Respiratory Failure. Chest. 2020;158(5):1992-2002.
Raboud J, Shigayeva A, McGeer A, Bontovics E, Chapman M, Gravel D, Henry B, et al. Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS One. 2010; 5(5):e10717.
Wilder-Smith A, Low JG. Risk of respiratory infections in health care workers: lessons on infection control emerge from the SARS outbreak. Southeast Asian J Trop Med Public Health. 2005;36(2):481-488.
Li J, Fink JB, Ehrmann S. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J. 2020; 55(5):2000892.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Médicas UIS